Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, GLADSTONE INVESTMENT CORPORATIONDE insiders bought a net $39.2K of stock across 18 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on May 19, 2026.
+1.8% median (+1.6% mean) 90-day return after 3 previous buys.
The trade is 34.5% of the 4,352 shares held after it.
No other insider bought within 30 days.
Insider activity: Chief Financial Officer Ritchie Taylor bought about $24.3K of GAIN on Aug 18, 2026, the largest insider purchase at the company since 2023.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 19.2% of the 2,347 shares held after it.
No other insider bought within 30 days.
Insider activity: Chief Financial Officer Ritchie Taylor bought about $7.4K of GAIN on May 15, 2026, the largest insider purchase at the company since 2023.
18 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt GAIN
FY Mar 2026
-0.18x
FY Mar 2025
0.04x
FY Mar 2024
-0.18x
FY Mar 2023
-0.02x
FY Mar 2022
n/a
Jun 2026
-0.08x
Mar 2026
-0.18x
Dec 2025
-0.01x
Sep 2025
-0.31x
Jun 2025
-0.09x
Mar 2025
0.04x
Dec 2024
-0.17x
Sep 2024
0.30x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+29.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GAIN
FY Mar 2026
+31.7%
FY Mar 2025
+13.2%
FY Mar 2024
+18.3%
FY Mar 2023
+8.0%
FY Mar 2022
n/a
Jun 2026
+29.2%
Mar 2026
+31.7%
Dec 2025
+22.2%
Sep 2025
+18.7%
Jun 2025
+16.5%
Mar 2025
+13.2%
Dec 2024
+14.7%
Sep 2024
+8.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+14.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GAIN
FY Mar 2026
+15.9%
FY Mar 2025
+6.7%
FY Mar 2024
+10.0%
FY Mar 2023
+4.7%
FY Mar 2022
n/a
Jun 2026
+14.0%
Mar 2026
+15.9%
Dec 2025
+10.3%
Sep 2025
+9.2%
Jun 2025
+8.1%
Mar 2025
+6.7%
Dec 2024
+7.0%
Sep 2024
+4.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital GAIN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed GAIN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
19.25x
close 2026-10-26 over four quarters of diluted EPS, 2024-04-01 to 2025-03-31
P/E, trailing GAIN
FY Mar 2026
18.68x
FY Mar 2025
17.58x
FY Mar 2024
22.95x
FY Mar 2023
11.94x
FY Mar 2022
n/a
Jun 2026
20.34x
Mar 2026
18.68x
Dec 2025
18.38x
Sep 2025
18.18x
Jun 2025
18.78x
Mar 2025
17.58x
Dec 2024
18.66x
Sep 2024
15.05x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.1B
market value at close 2026-10-26 on 2026-08-05 shares, plus long-term debt only, 2026-06-30, minus cash 2025-06-30
Enterprise value GAIN
FY Mar 2026
$1.1B
FY Mar 2025
$933.6M
FY Mar 2024
$906.6M
FY Mar 2023
$733.2M
FY Mar 2022
n/a
Jun 2026
$1.2B
Mar 2026
$1.1B
Dec 2025
$1.1B
Sep 2025
$1.1B
Jun 2025
$1.0B
Mar 2025
$933.6M
Dec 2024
$1.0B
Sep 2024
$869.2M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield GAIN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.85x
P/E over trailing EPS growth of 23%: four quarters to 2025-03-31 against the four to 2024-03-31
PEG, trailing GAIN
FY Mar 2026
0.83x
FY Mar 2025
0.78x
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
0.90x
Mar 2026
0.83x
Dec 2025
0.81x
Sep 2025
0.81x
Jun 2025
0.83x
Mar 2025
0.78x
Dec 2024
n/a
Sep 2024
0.54x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GAIN ranks highest on profitability (97th percentile) and risk and compliance (82nd), and lowest on financial health (27th), among Funds & Trusts peers.
Profitability
97
Inputs
Return on equity+29.2% · 97 pct, sector of 37
Return on assets+14.0% · 97 pct, sector of 38
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
27
Inputs
Debt to equity0.88x · 29 pct, universe of 3,589
Cash flow to debt-0.08x · 24 pct, sector of 30
Insider conviction
33
Inputs
Net Form 4 buying (codes P and S), 180d$39K · 51 pct, sector of 142
Insider buyers, 180d1 · 14 pct, sector of 142
Risk and compliance
82
Inputs
Short interest, % of shares outstanding (no float on file)+0.8% · 82 pct, sector of 46
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Growth, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GAIN filings, in plain words
Are Gladstone Investment Corporationde insiders buying or selling GAIN?
In the 180 days to 2026-10-28, Gladstone Investment Corporationde insiders were net buyers, a net $39.2K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-28, Gladstone Investment Corporationde insiders were net buyers of GAIN, a net $39.2K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.